2.1(top 20%)
impact factor
12.6K(top 2%)
papers
133.6K(top 5%)
citations
114(top 5%)
h-index
2.2(top 20%)
impact factor
20.3K
all documents
140.3K
doc citations
169(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1In-hospital mortality and morbidity of elderly medical patients can be predicted at admission by the Modified Early Warning Score: a prospective studyInternational Journal of Clinical Practice2009670
2Characterising the castration-resistant prostate cancer population: a systematic reviewInternational Journal of Clinical Practice2011614
3Prevalence of hypogonadism in males aged at least 45 years: the HIM studyInternational Journal of Clinical Practice2008601
4Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and updateInternational Journal of Clinical Practice2012446
5Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemiaInternational Journal of Clinical Practice2006400
6The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveysInternational Journal of Clinical Practice2007393
7The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a reviewInternational Journal of Clinical Practice2008387
8Health benefits of physical activity in older patients: a reviewInternational Journal of Clinical Practice2009374
9Quality of life and childhood atopic dermatitis: the misery of living with childhood eczemaInternational Journal of Clinical Practice2006369
10Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic reviewInternational Journal of Clinical Practice2009366
11Assessment and characterisation of post‐COVID‐19 manifestationsInternational Journal of Clinical Practice2021352
12The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseasesInternational Journal of Clinical Practice2009348
13Understanding heterogeneity in meta-analysis: the role of meta-regressionInternational Journal of Clinical Practice2009323
14DPP-4 inhibitors and their potential role in the management of type 2 diabetesInternational Journal of Clinical Practice2006311
15Help-seeking behaviour for sexual problems: the Global Study of Sexual Attitudes and BehaviorsInternational Journal of Clinical Practice2005296
16Neurobiology of depression: an integrated view of key findingsInternational Journal of Clinical Practice2007292
17Opioid-induced bowel dysfunction: prevalence, pathophysiology and burdenInternational Journal of Clinical Practice2007284
18SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rateInternational Journal of Clinical Practice2020283
19Communication in healthcare: a narrative review of the literature and practical recommendationsInternational Journal of Clinical Practice2015282
20Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trialInternational Journal of Clinical Practice2013281
21Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trialInternational Journal of Clinical Practice2012258
22Characteristics and healthcare costs of patients with fibromyalgia syndromeInternational Journal of Clinical Practice2007252
23The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective studyInternational Journal of Clinical Practice2013252
24The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patientsInternational Journal of Clinical Practice2003252
25Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInternational Journal of Clinical Practice2007235
26The mean platelet volume in patients with obesityInternational Journal of Clinical Practice2005234
27Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?International Journal of Clinical Practice2014231
28Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trialInternational Journal of Clinical Practice2009229
29Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literatureInternational Journal of Clinical Practice2011228
30One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trialInternational Journal of Clinical Practice2011221
31Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetesInternational Journal of Clinical Practice2006220
32Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?International Journal of Clinical Practice2012220
33The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12International Journal of Clinical Practice2008216
34GIDEON (Global Investigation of therapeutic DE cisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysisInternational Journal of Clinical Practice2014215
35Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United StatesInternational Journal of Clinical Practice2010214
36Complementary and alternative medicine use in England: results from a national surveyInternational Journal of Clinical Practice2010214
37Denosumab: mechanism of action and clinical outcomesInternational Journal of Clinical Practice2012211
38Patient adherence to medication requirements for therapy of type 2 diabetesInternational Journal of Clinical Practice2011210
39The importance of weight management in type 2 diabetes mellitusInternational Journal of Clinical Practice2014209
40Pharmacology of phosphodiesterase-5 inhibitorsInternational Journal of Clinical Practice2002206
41Metabolic side effects of antipsychotic medicationInternational Journal of Clinical Practice2007200
42Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinomaInternational Journal of Clinical Practice2008199
43Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?International Journal of Clinical Practice2013199
44Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensusInternational Journal of Clinical Practice2010197
45Frequency, signs and symptoms, and criteria adopted for long COVID‐19: A systematic reviewInternational Journal of Clinical Practice2021197
46When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmedInternational Journal of Clinical Practice2013193
47The medicinal use of cannabis in the UK: results of a nationwide surveyInternational Journal of Clinical Practice2004189
48Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled studyInternational Journal of Clinical Practice2009187
49Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase III studiesInternational Journal of Clinical Practice2013186
50Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year studyInternational Journal of Clinical Practice2010185